|
OGT expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.84977999999614E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.211400E-04 |
| Normal-vs-Stage2 |
2.981400E-03 |
| Normal-vs-Stage3 |
4.658500E-03 |
| Normal-vs-Stage4 |
4.120400E-03 |
| Stage1-vs-Stage2 |
2.913400E-01 |
| Stage1-vs-Stage3 |
9.429000E-01 |
| Stage1-vs-Stage4 |
4.509600E-01 |
| Stage2-vs-Stage3 |
3.879400E-01 |
| Stage2-vs-Stage4 |
8.255200E-01 |
| Stage3-vs-Stage4 |
5.191400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.14560000000908E-05 |
| Normal-vs-AfricanAmerican |
3.861100E-03 |
| Normal-vs-Asian |
3.650000E-02 |
| Caucasian-vs-AfricanAmerican |
4.987600E-01 |
| Caucasian-vs-Asian |
5.785800E-02 |
| AfricanAmerican-vs-Asian |
1.093010E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.600400E-04 |
| Normal-vs-Female |
2.14060000000016E-05 |
| Male-vs-Female |
2.012000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.360200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.70702999999772E-05 |
| Normal-vs-Age(61-80Yrs) |
9.998100E-04 |
| Normal-vs-Age(81-100Yrs) |
1.408840E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.199200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.209400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.239800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.045400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.397000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.185600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.492200E-02 |
| Normal-vs-Grade 2 |
1.420020E-04 |
| Normal-vs-Grade 3 |
7.039700E-04 |
| Normal-vs-Grade 4 |
1.492290E-02 |
| Grade 1-vs-Grade 2 |
2.280200E-01 |
| Grade 1-vs-Grade 3 |
1.934590E-01 |
| Grade 1-vs-Grade 4 |
2.525200E-01 |
| Grade 2-vs-Grade 3 |
7.515400E-01 |
| Grade 2-vs-Grade 4 |
8.720200E-01 |
| Grade 3-vs-Grade 4 |
9.480800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.40720000000061E-05 |
| Normal-vs-ccB subtype |
4.762400E-03 |
| ccA subtype-vs-ccB subtype |
3.744600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.8826999999928E-05 |
| Normal-vs-N1 |
4.788400E-01 |
| N0-vs-N1 |
4.780800E-01 |
|
|
